Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
antibiotics
2
×
biotech
clinical trials
deals
2
×
life sciences
national blog main
new york blog main
san diego blog main
san diego top stories
startups
abbvie
achaogen
adalimumab (humira)
adams street partners
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
axial spondyloarthritis
bausch health
beta lactamase inhibitor
biogen
biomedical advanced research and development authority (barda)
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
cluster headache
crispr
detroit blog main
detroit top stories
diagnostics
digital health
What
drug
approval
bacteria
bio
biogen’s
biopharma
biopharmaceutical
business
companies
company
convo
disease
earlier
exited
failures
fighting
infections
infectious
launches
littered
medicines
melinta
nash
new
news
price
products
qpex
remains
resistant
road
roundup
sold
strategy
tackle
talk
therapeutics
year
Language
Current search:
antibiotics
×
photo
×
deals
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections